4D Molecular Therapeutics, Inc. (FDMT)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS) Primary $
12. 14
-0.73
-5.6721%
$
696.84M Market Cap
- P/E Ratio
- Div Yield
794,500 Volume
-3.06 Eps
$ 12.87
Previous Close 
Want to track FDMT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
4D Molecular Therapeutics, Inc. (FDMT) Statistics
Valuation metrics
Market Cap 696.84M
Enterprise value 639.51M
Trailing P/E (ttm) -4.46
Forward P/E -
PEG ratio -0.3
Price/Sales (ttm) 7.29
Price/Book (mrq) 2.09
Enterprise Value/Revenue 6.95
Enterprise Value/EBITDA -3.48
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 810.61K
Average volume (90 days) 942.89K
Price summary
52-Week low 6.96
52-Week high 16.93
Beta -
50-Day moving average 13.92
200-Day moving average 11.51
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.95%
Operating margin -2.14%
Operational effectiveness
Return on assets -0.36%
Return on equity -0.41%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.31
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.55
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 5.14
Total debt (mrq) -
Total Debt/Equity (mrq) 0.1
Current ratio (mrq) 8.03%
Book value per share (mrq) 5.8
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
